CLSI POCT14

Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE

Clinical and Laboratory Standards Institute, 07/27/2020

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:27/07/2020

Pages:68

File Size:1 file , 6.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.

More CLSI standard pdf

CLSI GP17-A3 (R2018)

Clinical Laboratory Safety; Approved Guideline - Third Edition, GP17A3E

$90.00 $180.00

CLSI MM01-A3

Molecular Methods for Clinical Genetics and Oncology Testing; Approved Guideline-Third Edition, MM01A3E

$90.00 $180.00

CLSI EP17-A2 (R2018)

Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline- Second Edition, EP17A2E

$90.00 $180.00

CLSI M11-A8

Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard - Eighth Edition, M11A8E

$90.00 $180.00